What to Know About Stem Cell Transplants
A stem cell transplant is a procedure that replaces defective or damaged cells in patients whose normal blood cells have been affected by cancer. Stem cell transplants commonly are used to treat leukemia and lymphoma, cancers that affect the blood and lymphatic system. They also can help patients recover from or better tolerate cancer treatment.
In addition, these stem cell transplants are used to treat hereditary blood disorders, such as sickle cell anemia, and autoimmune diseases, such as multiple sclerosis.
Stem cell transplants use hematopoietic stem cells. These immature cells begin life in the bone marrow and eventually develop into the various types of mature blood cells, including:
- Red blood cells, which carry oxygen.
- Platelets, which help the blood clot.
- White blood cells, which help fight infection.
There are two types of stem cell transplantation:
Autologous stem cell transplant
Cells are harvested from the patient's own bone marrow before chemotherapy and are replaced after cancer treatment. These are used most often to treat diseases like lymphoma and myeloma. They have little to no risk of rejection or graft versus host disease (GVHD) and are therefore safer than allogeneic transplants.
Allogeneic stem cell transplant
Stem cells come from a donor whose tissue most closely matches the patient. These cells can also come from umbilical cord blood extracted from the placenta after birth and saved in special cord blood banks for future use. MD Anderson's Cord Blood Bank actively seeks donations of umbilical cords.
Allogeneic transplants are often used to treat diseases that involve bone marrow, such as leukemia. Unlike autologous transplants, they generate a new immune system response to fight cancer. Their downside is an increased risk of rejection or GVHD.
Finding stem cell donors
Stem cell transplant patients are matched with eligible donors by human leukocyte antigen (HLA) typing. HLA are proteins that exist on the surface of most cells in the body. HLA markers help the body distinguish normal cells from foreign cells, such as cancer cells.
HLA typing is done with a patient blood sample, which is then compared with samples from a family member or a donor registry. It can sometimes take several weeks or longer to find a suitable donor.
The closest possible match between the HLA markers of the donor and the patient reduces the risk of the body rejecting the new stem cells (graft versus host disease).
The best match is usually a first degree relative (children, siblings or parents). These can be full matches or half-match related transplants, also known as haploidentical transplants. However, about 75% of patients do not have a suitable donor in their family and require cells from matched unrelated donors (MUD), who are located through registries such as the National Marrow Donor Program.
Stem cell transplant side effects
Because the patient’s immune system is wiped out before a stem cell transplant, it takes about six months to a year for the immune system to recover and start producing healthy new blood cells. Transplant patients are at increased risk for infections during this time, and must take precautions. Other side effects include:
- Graft versus host disease (GVHD): This condition occurs when the body’s immune cells attack cells from the donor, or when the donor cells attack your cells. GVHD can occur right after the transplant or more than a year later.
- Increased risk of bleeding
- Anemia: Some patients may require a blood transfusion to treat persistent low red blood cell counts.
- Mouth sores
Stem Cell Transplantation and Cellular Therapy Center
Appointments at MD Anderson
Our Health Information Specialists can answer your questions about MD Anderson and help you schedule an appointment.
- To speak with a Health Information Specialist, call 877-632-6789.
Stem Cells, Clinical Trials Lead to Remission
When Sandra Hurley was diagnosed with CLL in 1997, an Ohio-based oncologist gave her just two to four years to live. “After I went through the shock…I just thought, ‘This is unacceptable.’”
Two Stem Cell Transplants Benefit Myeloma Patient
Don Kendall was able to complete virtually all his treatment as an outpatient. Almost two years later he is managing his cancer much like a chronic condition such as diabetes.
Chemistry professor Bindu Chakravarty rarely missed a day teaching at Houston Community College. So when she called in sick one morning, it was with good reason.
Stem Cell Patient Finds Hope After Third Diagnosis
“The drugs were not new, but the combination was. So when I was given the option for a clinical trial, I took it.”
Understanding Stem Cell Transplants
Borje S. Andersson, M.D., Ph.D., explains the different types of stem cell transplants, what makes a good donor match, and the latest stem cell transplant research at MD Anderson.